1.
Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects
by Lill, Christina M
Journal of medical genetics, 2012, Vol.49 (9), p.558-562
2.
PET Imaging of Tau Deposition in the Aging Human Brain
by Schöll, Michael
Neuron (Cambridge, Mass.), 2016, Vol.89 (5), p.971-982
3.
Genome-wide Association Analysis Reveals Putative Alzheimer's Disease Susceptibility Loci in Addition to APOE
by Bertram, Lars
American journal of human genetics, 2008, Vol.83 (5), p.623-632
4.
Candidate genes for temporal lobe epilepsy: a replication study
by Salzmann, Annick
Neurological sciences, 2008, Vol.29 (6), p.397-403
5.
Rosiglitazone Monotherapy in Mild-to-Moderate Alzheimer’s Disease: Results from a Randomized, Double-Blind, Placebo-Controlled Phase III Study
by Gold, Michael
Dementia and geriatric cognitive disorders, 2010, Vol.30 (2), p.131-146
6.
Apolipoprotein E Variation at the Sequence Haplotype Level: Implications for the Origin and Maintenance of a Major Human Polymorphism
by Fullerton, Stephanie M
American journal of human genetics, 2000, Vol.67 (4), p.881-900
7.
Dysexecutive versus amnesic phenotypes of very mild Alzheimer's disease are associated with distinct clinical, genetic and cortical thinning characteristics
by Dickerson, Bradford C
Journal of neurology, neurosurgery and psychiatry, 2011, Vol.82 (1), p.45-51
8.
CSF amyloid-β and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study
by Alves, Guido
Journal of neurology, neurosurgery and psychiatry, 2010, Vol.81 (10), p.1080-1086
10.
Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysis
by Factor, Stewart A
Journal of neurology, neurosurgery and psychiatry, 2011, Vol.82 (5), p.564-568
11.
Vascular Risk Factors and Dementia: 40-Year Follow-Up of a Population-Based Cohort
by Rönnemaa, Elina
Dementia and geriatric cognitive disorders, 2011, Vol.31 (6), p.460-466
12.
Impact of SORL1 Single Nucleotide Polymorphisms on Alzheimer’s Disease Cerebrospinal Fluid Markers
by Alexopoulos, Panagiotis
Dementia and geriatric cognitive disorders, 2011, Vol.32 (3), p.164-170
13.
Oxidative Damage Is the Earliest Event in Alzheimer Disease
by NUNOMURA, AKIHIKO
Journal of neuropathology and experimental neurology, 2001, Vol.60 (8), p.759-767
14.
Age at Onset in Two Common Neurodegenerative Diseases Is Genetically Controlled
by Li, Yi-Ju
American journal of human genetics, 2002, Vol.70 (4), p.985-993
15.
Decreased Expression and Activity of Neprilysin in Alzheimer Disease Are Associated With Cerebral Amyloid Angiopathy
by Miners, James Scott
Journal of neuropathology and experimental neurology, 2006, Vol.65 (10), p.1012-1021
16.
Fat Intake at Midlife and Risk of Dementia and Alzheimer’s Disease: A Population-Based Study
by Laitinen, M.H
Dementia and geriatric cognitive disorders, 2006, Vol.22 (1), p.99-107
17.
An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology
by Wider, Christian
Journal of neurology, neurosurgery and psychiatry, 2012, Vol.83 (4), p.424-429
18.
APOE4 predicts amyloid-β in cortical brain biopsy but not idiopathic normal pressure hydrocephalus
by Pyykkö, Okko T
Journal of Neurology, Neurosurgery & Psychiatry, 2012, Vol.83 (11), p.1119-1124
19.
Dopamine Receptor Genes Modulate Associative Memory in Old Age
by Papenberg, Goran
Journal of cognitive neuroscience, 2017, Vol.29 (2), p.245-253
20.
Influence of APOE polymorphism on cognitive and behavioural outcome in moderate and severe traumatic brain injury
by Ariza, M
Journal of neurology, neurosurgery and psychiatry, 2006, Vol.77 (10), p.1191-1193
